Precisio Biotix begins extended ClyO treatment for chronic prosthetic joint infection
Precisio Biotix reports early ClyO use in chronic prosthetic joint infection, highlighting its promise, evidence limits and regulatory hurdles.
Precisio Biotix reports early ClyO use in chronic prosthetic joint infection, highlighting its promise, evidence limits and regulatory hurdles.
Mitria Medical's Subvalvular Spacer reaches the U.S. under FDA compassionate use. What it means for FMR patients and what clinical evidence still needs to come.
FDA allows compassionate use of urcosimod for neuropathic corneal pain. Read how this decision reshapes regulatory, clinical, and development risk.